XOZYRLI
"XOZYRLI" is a word mark owned by Teva Pharmaceutical Industries Ltd., filed at the CIPO on November 12, 2024. It is in its opposition period and covers class 5 (Pharmaceuticals).
- Status
- Opposition period
- Since August 26, 2026
- Filed
- November 12, 2024
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 2361537
- Registration no.
- Not yet
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns XOZYRLI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Teva Pharmaceutical Industries Ltd.
Israel
Representative
Osler, Hoskin & Harcourt LLP
Osler, Hoskin & Harcourt LLP
What the mark covers
The products and services XOZYRLI is filed for, grouped by Nice class.
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmic disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.
What has happened so far
Steps recorded by the CIPO, newest first.
- Advertised; Vol.73 Issue 3748
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Examiner's First Report
- Search Recorded
- Pre-Assessment Letter Sent; Goods or Services Not Acceptable
- Formalized
- Created
- Filed
About XOZYRLI
Who owns the trademark "XOZYRLI"?
The CIPO trademark "XOZYRLI" (application 2361537) is owned by Teva Pharmaceutical Industries Ltd.
What is the status of "XOZYRLI"?
Its status at the CIPO is: opposition period.
Get this data via the API
Everything on this page comes from the Signa API. Pull XOZYRLI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb4e-ff66-749d-bce0-6bd3d88542f6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb4e-ff66-749d-bce0-6bd3d88542f6",
"object": "trademark",
"mark_text": "XOZYRLI",
"status": {
"primary": "pending",
"stage": "pending_opposition"
},
"office_code": "CA",
"application_number": "2361537",
"filing_date": "2024-11-12",
"nice_classes": [
5
],
"owners": [
{
"name": "Teva Pharmaceutical Industries Ltd.",
"entity_id": "ent_019ebbc5-6f32-7092-a649-5aaa7b712e21"
}
]
}